| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $963.6M | +24.0% |
| Cost of Revenue | $257.5M | +12.1% |
| Gross Profit | $706.2M | +29.0% |
| R&D Expense | $421.2M | +20.8% |
| SG&A Expense | $156.7M | +13.9% |
| Operating Income | -$419.1M | +12.5% |
| Pre-tax Income | -$334.7M | +17.7% |
| Income Tax | $10.4M | -71.2% |
| Net Income | -$345.1M | +22.1% |
| EPS (Basic) | -$1.07 | +27.2% |
| EPS (Diluted) | -$1.07 | +27.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $386.0M | +10.4% |
| Accounts Receivable | $314.3M | +36.7% |
| Current Assets | $2.35B | +4.4% |
| Total Assets | $2.69B | +9.5% |
| Current Liabilities | $589.2M | +21.0% |
| Long-term Debt | $1.09B | +0.4% |
| Total Liabilities | $1.73B | +5.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $33.5M | +132.3% |
| Capital Expenditures | $2.6M | -9.4% |
| Investing Cash Flow | -$75.0M | +11.6% |
| Financing Cash Flow | $79.8M | -22.0% |
| Free Cash Flow | $30.9M | +129.0% |
| Stockholders' Equity |
| $961.2M |
| +18.6% |